GlassScriptPhysician profile
Ammar A Alsheikh
NPI 1083609515
$5,982.00
in general payments reported to CMS, 2019-2025
60 companies · $456 in 2025
The $456 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $891 · 2020: $785 · 2021: $1,461 · 2022: $1,152 · 2023: $661 · 2024: $576 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,676 · Entertainment: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,675.74 |
| Entertainment | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $967.74 | 2019-2025 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $617.54 | 2019-2025 | Airsupra, Lokelma |
| Abbvie INC. | $555.19 | 2019-2025 | Ubrelvy, Qulipta, Synthroid |
| Lilly USA, LLC | $397.20 | 2019-2025 | Mounjaro, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $382.03 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $360.80 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbott Laboratories | $212.44 | 2019-2025 | Freestyle Libre 3 |
| Pfizer INC. | $212.28 | 2019-2025 | |
| Dexcom, INC. | $133.00 | 2022-2025 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $126.15 | 2019-2022 | |
| Allergan, INC. | $125.87 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $107.84 | 2019-2022 | |
| Amgen INC. | $83.10 | 2019-2024 | Krystexxa |
| Horizon Therapeutics Plc | $74.83 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $73.41 | 2019-2021 |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ammar Alsheikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.